Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Stroffolini

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 7, 2024
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?J Cusato, A Manca, A Palermiti, et al.
Life (Basel, Switzerland)|December 24, 2021
Serology for <i>Borrelia</i> spp. in Northwest Italy: A Climate-Matched 10-Year TrendGiacomo Stroffolini, Francesco Vladimiro Segala, Tommaso Lupia, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2024
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria?Alberto Gaviraghi, Amedeo de Nicolò, Francesco Venuti, et al.
Journal of Travel Medicine|July 2, 2024
Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysisSarah L McGuinness, Stephen Muhi, Maya L Nadimpalli, et al.
The Lancet. Infectious Diseases|February 18, 2024
Transjugular intrahepatic portosystemic shunt followed by splenectomy for complicated hepatosplenic schistosomiasis: a case report and review of the literatureFrancesca Tamarozzi, Tamara Ursini, Giacomo Stroffolini, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 31, 2023
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment RegimenGiacomo Stroffolini, Alessandro Lazzaro, Ambra Barco, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for CliniciansLuigi Principe, Tommaso Lupia, Lilia Andriani, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing AntibioticTommaso Lupia, Ilaria De Benedetto, Giacomo Stroffolini, et al.
The Journal of Infection|March 19, 2023
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsGiacomo Stroffolini, Alberto Gaviraghi, Daniele Penna, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Fluoroquinolones and Biofilm: A Narrative ReviewNicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 7, 2024
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?J Cusato, A Manca, A Palermiti, et al.
Life (Basel, Switzerland)|December 24, 2021
Serology for <i>Borrelia</i> spp. in Northwest Italy: A Climate-Matched 10-Year TrendGiacomo Stroffolini, Francesco Vladimiro Segala, Tommaso Lupia, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2024
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria?Alberto Gaviraghi, Amedeo de Nicolò, Francesco Venuti, et al.
Journal of Travel Medicine|July 2, 2024
Patient characteristics and antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae infections in international travellers: a GeoSentinel analysisSarah L McGuinness, Stephen Muhi, Maya L Nadimpalli, et al.
The Lancet. Infectious Diseases|February 18, 2024
Transjugular intrahepatic portosystemic shunt followed by splenectomy for complicated hepatosplenic schistosomiasis: a case report and review of the literatureFrancesca Tamarozzi, Tamara Ursini, Giacomo Stroffolini, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 31, 2023
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment RegimenGiacomo Stroffolini, Alessandro Lazzaro, Ambra Barco, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for CliniciansLuigi Principe, Tommaso Lupia, Lilia Andriani, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing AntibioticTommaso Lupia, Ilaria De Benedetto, Giacomo Stroffolini, et al.
The Journal of Infection|March 19, 2023
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsGiacomo Stroffolini, Alberto Gaviraghi, Daniele Penna, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Fluoroquinolones and Biofilm: A Narrative ReviewNicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
Pageof 5